Goldenberg, David M.

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

Bardia, A., Hurvitz, S. A., Tolaney, S. M., Loirat, D., Punie, K., Oliveira, M., Brufsky, A., Sardesai, S. D., Kalinsky, K., Zelnak, A. B., et al. (2021) · New England Journal of Medicine

Breast Cancer Treatment StudiesCancer Treatment and Pharmacology

Cited by 1,711

Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer

Bardia, A., Mayer, I. A., Vahdat, L. T., Tolaney, S. M., Isakoff, S. J., Diamond, J. R., O’Shaughnessy, J., Moroose, R. L., Santin, A. D., Abramson, V. G., et al. (2019) · New England Journal of Medicine

Breast Cancer Treatment StudiesAdvanced Breast Cancer Therapies

Cited by 874

Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting

Rossi, E. A., Goldenberg, D. M., Cardillo, T. M., McBride, W. J., Sharkey, R. M., & Chang, C.-H. (2006) · Proceedings of the National Academy of Sciences

Radiopharmaceutical Chemistry and ApplicationsMonoclonal and Polyclonal Antibodies Research

Cited by 209

Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab

Carnahan, J., Stein, R., Qu, Z., Hess, K., Cesano, A., Hansen, H. J., & Goldenberg, D. M. (2007) · Molecular Immunology

Lymphoma Diagnosis and TreatmentMonoclonal and Polyclonal Antibodies Research

Cited by 175

Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls

Jacobi, A. M., Goldenberg, D. M., Hiepe, F., Radbruch, A., Burmester, G. R., & Dörner, T. (2008) · Annals of the Rheumatic Diseases

Systemic Lupus Erythematosus ResearchT-cell and B-cell Immunology

Cited by 127

PAM4-Reactive MUC1 Is a Biomarker for Early Pancreatic Adenocarcinoma

Gold, D. V., Karanjawala, Z., Modrak, D. E., Goldenberg, D. M., & Hruban, R. H. (2007) · Clinical Cancer Research

Pancreatic and Hepatic Oncology ResearchGlycosylation and Glycoproteins Research

Cited by 93

Improved Therapeutic Results by Pretargeted Radioimmunotherapy of Non–Hodgkin's Lymphoma with a New Recombinant, Trivalent, Anti-CD20, Bispecific Antibody

Sharkey, R. M., Karacay, H., Litwin, S., Rossi, E. A., McBride, W. J., Chang, C.-H., & Goldenberg, D. M. (2008) · Cancer Research

Radiopharmaceutical Chemistry and ApplicationsMonoclonal and Polyclonal Antibodies Research

Cited by 75